| Application no. and date | 21827309.2 (espacenet) (Federated) (European Patent Register), 20211119 | | Patent/reg. no. and date | DK/EP 4247813, 20251224 | | Publication date | 20230927 | | Priority no. and date | US 202063116703 P, 20201120 | | EP pub. no. and date |
EP 4247813 20230927 | | Effective date | | | Applicant/owner | Amgen, Inc, One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | 2043791 | | Inventor | CORBETT, Michael T.,
Thousand Oaks, California 91320-1799, US,
ACHMATOWICZ, Michal,
Thousand Oaks, California 91320-1799, US,
COYLER, John T.,
Thousand Oaks, California 91320-1799, US,
GRIFFIN, Daniel J.,
Thousand Oaks, California 91320-1799, US,
PARSONS, Andrew T.,
Thousand Oaks, California 91320-1799, US,
ROBINSON, Joanna,
Thousand Oaks, California 91320-1799, US,
QUASDORF, Kyle,
Thousand Oaks, CA 91320- 1799, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 471/04 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF 7-CHLOR-6-FLUOR-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3- YL)PYRIDOF[2,3-D]PYRIMIDIN-2,4(1 H,3 H)-DION | | Int. application no. | US2021060048 | | Int. publication no. | WO2022109242 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
